Volitinib
Volitinib
Volitinib (pronounced vo-li-ti-nib) is a type of cancer drug that is used in the treatment of various types of cancers. It is a tyrosine kinase inhibitor, which works by blocking certain proteins in the body that can affect the growth and spread of cancer cells.
Etymology
The name "Volitinib" is derived from the Latin word "volit", meaning "to fly", and the suffix "-nib", which is commonly used in the names of tyrosine kinase inhibitors. The name suggests the drug's ability to swiftly and effectively target and inhibit the growth of cancer cells.
Usage
Volitinib is used in the treatment of certain types of gastrointestinal stromal tumors (GISTs) that cannot be treated with surgery or other drugs. It is also being studied in the treatment of other types of cancer.
Related Terms
- Tyrosine kinase inhibitor: A type of drug that blocks the action of enzymes known as tyrosine kinases, which can affect the growth and spread of cancer cells.
- Gastrointestinal stromal tumor (GIST): A type of tumor that occurs in the gastrointestinal tract, often in the stomach or small intestine.
Side Effects
Like all drugs, Volitinib can cause side effects. These may include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include liver damage and heart problems.
See Also
External links
- Medical encyclopedia article on Volitinib
- Wikipedia's article - Volitinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski